Clinical Omics – News and Features

This article delves into MS data analysis and its associated challenges, how AI/ML can aid analyses and exciting potential future developments in the field, with specific applications to proteomics and metabolomics research.

Precision diagnostics for diseases that affect the brain and other organs brought closer by new ability to exclusively access contents of organ-derived extracellular vesicles in blood.

Researchers have established the English National Lynch Syndrome Registry, the UK’s first comprehensive database for patients with Lynch syndrome. This initiative links genomic data with cancer diagnosis and treatment information.

Newborn screening is a relatively easy and cost-effective way of improving the identification of babies with a medical condition in a timely fashion. This allows newborns to receive the treatment needed before irreversible damage has developed.

Bruker Corporation officially opened its new production facility in Bremen – one of Germany’s major science hubs – last week. Technology Networks visited the facility to learn about its low carbon footprint and how it will support Bruker's commitment to innovation and collaboration.

Proteomics provides insights into the regulation of biological processes and mechanisms of disease. In this article, we explore approaches scientists are using to find early markers of disease, new drug targets and strategies to overcome resistance to treatments.

Researchers have developed a machine learning-based classifier, which utilizes metabolic profiles of serum samples, to accurately identify people with ovarian cancer.

A new study led by Stanford Medicine scientists demonstrates a simple way of studying organ aging by analyzing distinct proteins, or sets of them, in blood, enabling the prediction of individuals’ risk for diseases.

A test that analyzes specific sets of proteins in the blood can tell us how fast each of our organs is aging, enabling the prediction of disease risk and earlier intervention.

Proteomics methods are now applied across a variety of scientific disciplines. In this article, we explore just some of the recent trends and advancements in high-throughput and single-cell proteomics.